Evofem Biosciences, Inc.·4

Nov 18, 5:22 PM ET

File Justin J. 4

4 · Evofem Biosciences, Inc. · Filed Nov 18, 2020

Insider Transaction Report

Form 4
Period: 2020-11-17
File Justin J.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-11-17$2.17/sh+7,760$16,839258,168 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file
  • 4
    wf-form4_160573815596283.xmlPrimary

    FORM 4